These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2955 related articles for article (PubMed ID: 26928656)

  • 21. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
    Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
    J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
    Raimondo S; Giavaresi G; Lorico A; Alessandro R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preservation and Storage Stability of Extracellular Vesicles for Therapeutic Applications.
    Jeyaram A; Jay SM
    AAPS J; 2017 Nov; 20(1):1. PubMed ID: 29181730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis.
    Zarà M; Guidetti GF; Camera M; Canobbio I; Amadio P; Torti M; Tremoli E; Barbieri SS
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos.
    Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG
    Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nature's carriers: leveraging extracellular vesicles for targeted drug delivery.
    Chen Q; Zheng Y; Jiang X; Wang Y; Chen Z; Wu D
    Drug Deliv; 2024 Dec; 31(1):2361165. PubMed ID: 38832506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
    Kooijmans SAA; de Jong OG; Schiffelers RM
    Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
    Ingato D; Lee JU; Sim SJ; Kwon YJ
    J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.
    Rezaie J; Nejati V; Mahmoodi M; Ahmadi M
    Biochem Pharmacol; 2022 Sep; 203():115167. PubMed ID: 35820499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
    Burnouf T; Agrahari V; Agrahari V
    Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.
    O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
    Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines.
    Kotmakçı M; Bozok Çetintaş V
    J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
    Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
    Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems.
    Lu M; Xing H; Xun Z; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Sci; 2018 Aug; 121():34-46. PubMed ID: 29733979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular Vesicles as Drug Transporters.
    Nowak M; Górczyńska J; Kołodzińska K; Rubin J; Choromańska A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
    Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
    Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 148.